Medicus Pharma Ltd. (MDCX) Institutional Ownership

Ownership Summary

Recent 13F filings as of December 2025 show that 5 institutional investors hold a position in Medicus Pharma Ltd. (NASDAQ:MDCX).

• The collective stake of institutional investors in Medicus Pharma moved to 8.9% in December 2025, a shift down from the 11.5% reported for September 2025.
• Institutional share ownership changed by 1.48% QoQ, while the number of institutional owners saw an increase of 25.00% YoY.
• A review of institutional activity for Medicus Pharma shows 2 of 5 filers increasing their positions, while 0 reduced their stake, and 3 remained unchanged.
• The total number of shares held by institutions in Medicus Pharma increased to 1.66Mn as of December 2025, a net change of up by 24.09K shares quarter on quarter, and up 152.71K shares year over year.
• Interchange Capital Partners, LLC continues to be the largest institutional holder of Medicus Pharma as of December 31, 2025, with a position of 1.59Mn shares, representing 8.49% of the company's outstanding stock.
• Among the most significant buyers of Medicus Pharma during December 2025 were May Hill Capital, LLC (17.81K), UBS Group AG (6.27K).
• The top 5 institutional holders of Medicus Pharma for the quarter ending December 2025 included Interchange Capital Partners, LLC (1.59Mn), May Hill Capital, LLC (35.62K), BRAVE ASSET MANAGEMENT INC (20.00K), UBS Group AG (13.23K), DAGCO, INC. (349).